教員情報 - 石川　真穂 | 埼玉医科大学

教員情報トップぺージ

（最終更新日：2024-02-04 16:29:07）

  イシカワ　マホ   ISHIKAWA Maho
  石川　真穂
   所属   埼玉医科大学医学部国際医療センター　造血器腫瘍科

職種専任講師

■ 学術雑誌

1.	学術雑誌(原著)	A novel gene, ANKRD28 on 3p25, is fused with NUP98 on 11p15 in a cryptic 3-way translocation of t(3;5;11)(p25;q35;p15) in an adult patient with myelodysplastic syndrome/acute myelogenous leukemia. 2007/10
2.	学術雑誌(原著)	Clinical management of second-generation tyrosine kinase inhibitor therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase, focusing on age and dose effects 2023/05/02
3.	学術雑誌(原著)	Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide 2023/04/24
4.	学術雑誌(原著)	Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice. 2023/03/31
5.	学術雑誌(症例報告)	Paravertebral extramedullary hematopoiesis in a case of myelodysplastic syndrome with ring sideroblasts and an SF3B1 mutation 2022/06
6.	学術雑誌(原著)	Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors. 2022/04/29
7.	学術雑誌(原著)	Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial 2021/09/11
8.	学術雑誌(原著)	The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort 2020/12/09
9.	学術雑誌(原著)	Potential role for second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: a retrospective CML Cooperative Study Group analysis. 2019/09
10.	学術雑誌(症例報告)	The progression of severe aplastic anemia to hypoplastic leukemia in a long-term observation after the administration of pegylated rHuMGDF 2018/09
11.	学術雑誌(原著)	Comparative quantitative analysis of BCR-ABL transcripts with the T315I mutant clone by polymerase chain reaction (PCR)-Invader method. 2011/09
12.	学術雑誌(その他)	急性リンパ性白血病 2010/12
13.	学術雑誌(総説)	Ph陽性ALLのチロシンキナーゼ阻害剤による治療 2009/08
14.	学術雑誌(その他)	Long-term improvement of anaemia in a patient with aplastic anaemia by short-term administration of pegylated recombinant human megakaryocyte growth and development factor 2004/06
5件表示
全件表示(14件)

■ 学会発表

1.	Outcomes of CML patients not achieving optimal response at one year of TKI treatment （口頭発表，一般） 2023/10/14
2.	The effect of introduction of 2G-TKI as first-line therapy on CML treatment modalities and outcomes （口頭発表，一般） 2023/10/14
3.	Usefulness of new risk prediction model for VAEs in Japanese patients with CML treated with TKIs （口頭発表，一般） 2023/10/14
4.	実臨床での慢性骨髄性白血病患者の妊娠と出産（口頭発表，一般） 2023/10/14
5.	CML-CSGデータによる付加的染色体異常を有するCML患者の解析（口頭発表，一般） 2023/10/13
6.	チロシンキナーゼ阻害薬治療下の慢性骨髄性白血病患者における二次癌の検討（口頭発表，一般） 2023/10/13
7.	Successful treatment with dasatinib and chemotherapy for an ALL harboring a rare e13a3 BCR-ABL （口頭発表，一般） 2015/10/17
5件表示
全件表示(7件)